Holdings (41)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 9.60716181% |
| Ajanta Pharma Ltd. | Healthcare | Equity | 5.48406746% |
| Cipla Ltd. | Healthcare | Equity | 5.48174283% |
| Lupin Ltd. | Healthcare | Equity | 4.70441507% |
| Procter & Gamble Health Ltd. | Healthcare | Equity | 3.98592315% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 3.73824559% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 3.73708783% |
| Gland Pharma Ltd. | Healthcare | Equity | 3.61839514% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 3.57971518% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 3.56078087% |
Returns and rankings
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund Returns | 3.03% | 24.96% | 19.17% | 14.85% |
| Category Average | 0.70% | 21.36% | 17.62% | NA% |
| Rank Within Category | 4.00% | 2.00% | 5.00% | NA% |
Expense ratio, exit load and tax
Expense ratio: 1.3%
Inclusive of GST
Exit load
Exit load of 1% if redeemed within 30 days.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Fund management
Education
Mr. Gada is B.com, CA, CS, & CFA
Experience
Prior to joining UTI Mutual Fund he has worked with BPCL as Senior Accounts Officer.